These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23512961)

  • 21. The impact of agarose immobilization on the activity of lytic Pseudomonas aeruginosa phages combined with chemicals.
    Dorotkiewicz-Jach A; Markwitz P; Rachuna J; Arabski M; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2023 Feb; 107(2-3):897-913. PubMed ID: 36625915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Application of Impedance Spectroscopy for
    Guła G; Szymanowska P; Piasecki T; Góras S; Gotszalk T; Drulis-Kawa Z
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32272740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Pseudomonas aeruginosa Phage C11 and Identification of Host Genes Required for Virion Maturation.
    Cui X; You J; Sun L; Yang X; Zhang T; Huang K; Pan X; Zhang F; He Y; Yang H
    Sci Rep; 2016 Dec; 6():39130. PubMed ID: 28000703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic analysis of Pseudomonas aeruginosa phages LKD16 and LKA1: establishment of the phiKMV subgroup within the T7 supergroup.
    Ceyssens PJ; Lavigne R; Mattheus W; Chibeu A; Hertveldt K; Mast J; Robben J; Volckaert G
    J Bacteriol; 2006 Oct; 188(19):6924-31. PubMed ID: 16980495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and genomic study of "phiKMV-Like" phage PAXYB1 infecting Pseudomonas aeruginosa.
    Yu X; Xu Y; Gu Y; Zhu Y; Liu X
    Sci Rep; 2017 Oct; 7(1):13068. PubMed ID: 29026171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large Preferred Region for Packaging of Bacterial DNA by phiC725A, a Novel Pseudomonas aeruginosa F116-Like Bacteriophage.
    Pourcel C; Midoux C; Hauck Y; Vergnaud G; Latino L
    PLoS One; 2017; 12(1):e0169684. PubMed ID: 28060939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complete nucleotide sequence of phi CTX, a cytotoxin-converting phage of Pseudomonas aeruginosa: implications for phage evolution and horizontal gene transfer via bacteriophages.
    Nakayama K; Kanaya S; Ohnishi M; Terawaki Y; Hayashi T
    Mol Microbiol; 1999 Jan; 31(2):399-419. PubMed ID: 10027959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New Virulent Bacteriophages Active against Multiresistant Pseudomonas aeruginosa Strains].
    Balarjishvili NSh; Kvachadze LI; Kutateladze MI; Meskhi TSh; Pataridze TK; Berishvili TA; Tevdoradze ESh
    Prikl Biokhim Mikrobiol; 2015; 51(6):600-9. PubMed ID: 26859962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phages from Genus
    Knezevic P; Petrovic Fabijan A; Gavric D; Pejic J; Doffkay Z; Rakhely G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A carrier state is established in Pseudomonas aeruginosa by phage LeviOr01, a newly isolated ssRNA levivirus.
    Pourcel C; Midoux C; Vergnaud G; Latino L
    J Gen Virol; 2017 Aug; 98(8):2181-2189. PubMed ID: 28771128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequencing and characterization of Pseudomonas aeruginosa phage JG004.
    Garbe J; Bunk B; Rohde M; Schobert M
    BMC Microbiol; 2011 May; 11():102. PubMed ID: 21569567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa defends against phages through type IV pilus glycosylation.
    Harvey H; Bondy-Denomy J; Marquis H; Sztanko KM; Davidson AR; Burrows LL
    Nat Microbiol; 2018 Jan; 3(1):47-52. PubMed ID: 29133883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Phage-Encoded
    Ceyssens PJ; De Smet J; Wagemans J; Akulenko N; Klimuk E; Hedge S; Voet M; Hendrix H; Paeshuyse J; Landuyt B; Xu H; Blanchard J; Severinov K; Lavigne R
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32887488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa.
    Knezevic P; Curcin S; Aleksic V; Petrusic M; Vlaski L
    Res Microbiol; 2013 Jan; 164(1):55-60. PubMed ID: 23000091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of bacteriophages and their application to control Pseudomonas aeruginosa in planktonic and biofilm models.
    Kwiatek M; Parasion S; Rutyna P; Mizak L; Gryko R; Niemcewicz M; Olender A; Łobocka M
    Res Microbiol; 2017 Apr; 168(3):194-207. PubMed ID: 27818282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a novel Pseudomonas aeruginosa bacteriophage, KPP25, of the family Podoviridae.
    Miyata R; Yamaguchi K; Uchiyama J; Shigehisa R; Takemura-Uchiyama I; Kato S; Ujihara T; Sakaguchi Y; Daibata M; Matsuzaki S
    Virus Res; 2014 Aug; 189():43-6. PubMed ID: 24801109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and genome analysis of Pseudomonas aeruginosa phage vB_PaeP_Lx18 and the antibacterial activity of its lysozyme.
    Yin Y; Wang X; Mou Z; Ren H; Zhang C; Zou L; Liu H; Liu W; Liu Z
    Arch Virol; 2022 Sep; 167(9):1805-1817. PubMed ID: 35716268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery and Characterization of Bacteria Resisting Infection by Lytic Bacteriophage.
    Latino L; Pourcel C
    Methods Mol Biol; 2018; 1693():85-98. PubMed ID: 29119434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models.
    Tiwari BR; Kim S; Rahman M; Kim J
    J Microbiol; 2011 Dec; 49(6):994-9. PubMed ID: 22203564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.